Nanoparticle biosensors

• US 20090148863A1
• Filed: 09/11/2008
• Published: 06/11/2009
• Est. Priority Date: 11/30/2007
• Status: Abandoned Application

• Current Assignee: Old Dominion University Research Foundation
• Original Assignee: Old Dominion University (Commonwealth of Virginia)
• Inventors: Huang, Tao, Xu, Xiaohong Nancy, Nallathamby, Prakash
• Application Number:
  US12/232,184
• Publication Number:
  US 20090148863A1
• Time in Patent Office: Days
• US Class Current: 435/7.100
• CPC Class Codes: G01N 21/554 detecting the surface plasmon resonance of nanostructured metals, e.g. localised surface plasmon resonance
• CPC Class Codes: G01N 33/54346 Nanoparticles
• CPC Class Codes: G01N 33/553 Metal or metal coated
• CPC Class Codes: G01N 33/587 Nanoparticles

Abstract

Compositions which are useful in ultralow level of detection based on functionalized nanoparticles having exceptional combinations of properties including stability, brightness, binding specificity, and ability to be imaged at single nanoparticle resolution over desired period of time. The biological moieties on the nanoparticles preserve biological function. The nanoparticle surface can comprise a first monolayer component which is adapted to bind to a biological moiety. The biological moiety can be adapted to bind to an analyte. The nanoparticle surface can further comprise a second monolayer component, which is adapted to help expose the first monolayer component on the surface. Other components on the surface can help stabilize the nanoparticle. The nanoparticles are stable against aggregation, have photostability (non-photodecomposition and non-blinking), and can achieve single molecule detection in real time. Analytes can be detected at low levels both in solution and on surfaces such as cell surfaces.

Claims

1. A composition comprising:

at least one nanoparticle comprising a surface functionalized with at least one first monolayer component and at least one second monolayer component different from the first, wherein the molar ratio of the amount of the first monolayer component to the amount of the second monolayer component is adapted to provide a stability against aggregation of nanoparticles when a collection of the nanoparticles is dispersed in water.

2. The composition of claim 1, wherein the molar ratio of the amount of the first monolayer component to the amount of the second monolayer component is adapted to provide a stability of nanoparticles against their aggregation of at least seven days when a collection of the nanoparticles is dispersed in water, as measured by sizes and colors (spectra) of nanoparticles.

3. The composition of claim 1, wherein the molar ratio of the amount of the first monolayer component to the amount of the second monolayer component is adapted to provide a stability against aggregation of nanoparticles of at least 30 days when a collection of the nanoparticles is dispersed in water, as measured by sizes and colors (spectra) of nanoparticles.

4. The composition of claim 1, wherein the molar ratio of the amount of the first monolayer component to the amount of the second monolayer component is more than about 1:

1 to about 1;

20.

6. The composition of claim 1, wherein the first and second monolayer components are mercapto compounds.

7. The composition of claim 1, wherein the first and second monolayer components are mercapto compounds which each can be represented by A-B—

C, wherein A is a functional group which binds to the nanoparticle surface, C is a reactive or unreactive group, and B is a linking group.

9. The composition of claim 1, wherein the first monolayer component is adapted to bind to a biological moiety, and the first and second monolayer components are molecules, and the first monolayer component is longer than the second monolayer component.

10. The composition of claim 1, wherein the nanoparticle further comprises a third component at the surface.

11. The composition of claim 1, wherein the nanoparticle further comprises a third component at the surface which provides electrostatic charge to the surface.

13. The composition of claim 1, wherein the composition comprises the nanoparticles having an average particle size of about 1 nm to about 100 mm.

15. The composition of claim 1, wherein the first component is further functionalized with a biological moiety.

20. The composition of claim 1, wherein the first component is further functionalized with a biological moiety at an average ratio of about one nanoparticle to about 0.5 to about 1.5 biological moiety.

21. The composition of claim 1, wherein the nanoparticle is a metal nanoparticle.

22. The composition of claim 1, wherein the nanoparticle is a noble metal nanoparticle.

23. The composition of claim 1, wherein the nanoparticle is a silver nanoparticle.

25. The composition of claim 1, wherein the nanoparticle is dispersible in water.

26. The composition of claim 1, wherein the nanoparticle is not a fluorescent nanoparticle.

27. The composition of claim 1, wherein the nanoparticle is a noble metal nanoparticle, wherein the first and second monolayer components are mercapto compounds, and a third component is present, and the composition comprises the nanoparticles having an average particle size of about 1 nm to about 100 nm.

29. The composition of claim 1, wherein the nanoparticle is a noble metal nanoparticle dispersible in water, wherein the first component is further functionalized with a biological moiety and a third component is present, and the nanoparticle has a particle size of about 1 nm to about 100 nm, and wherein the molar ratio of the amount of the first monolayer component to the amount of the second monolayer component is adapted to provide a stability against aggregation when a collection of the nanoparticles is dispersed in water.

5. (canceled)

8. (canceled)

12. (canceled)

14. (canceled)

16-19. -19. (canceled)

24. (canceled)

28. (canceled)

30. (canceled)

31. A composition comprising:

at least one noble metal nanoparticle comprising a surface functionalized with at least one first monolayer component and at least one second monolayer component different from the first, wherein the first monolayer component is further functionalized with a biological moiety, and wherein the molar ratio of the amount of the first monolayer component to the amount of the second monolayer component is adapted to provide a stability against aggregation of nanoparticles when a collection of the nanoparticles is dispersed in water.

32-50. -50. (canceled)

51. A composition comprising:

at least one nanoparticle comprising a surface functionalized with at least one first monolayer component and at least one second monolayer component different from the first, wherein the molar ratio of the amount of the first monolayer component to the amount of the second monolayer component is adapted to provide a stability against aggregation of nanoparticles when a collection of the nanoparticles is dispersed in water, wherein the first component is further functionalized with a biological moiety for binding to an analyte.

55. The composition of claim 51, wherein the molar ratio of the amount of the first monolayer component to the amount of the second monolayer component is more than about 1:

1 to about 1;

5.

58. The composition of claim 51, wherein the first and second monolayer components are mercapto compounds which each can be represented by A-B—

C, wherein A is a functional group which binds to the nanoparticle surface, C is a reactive, and B is a linking group.

61. The composition of claim 51, wherein the nanoparticle further comprises a third component at the surface, which provides electrostatic charge to the surface.

63. The composition of claim 51, wherein the composition comprises the nanoparticles having an average particle size of about 1 nm to about 100 mm.

65. The composition of claim 51, wherein the biological moiety is a protein biological moiety, an antibody biological moiety, a monoclonal antibody biological moiety, or combinations thereof.

69. The composition of claim 51, wherein the first component is further functionalized with a biological moiety at an average ratio of about one nanoparticle to about 0.5 to about 1.5 biological moiety.

70. The composition of claim 51, wherein the nanoparticle is a noble metal nanoparticle.

71. A composition of claim 51, wherein the analyte is a peptide, protein, nucleic acid, drug, bio-mimetic, antibody, cell receptor, or combinations thereof.

77. composition of claim 51, wherein the analyte is an antibody, and the antibody is humanized chimeric, monoclonal, or combinations thereof.

101. A method comprising:

providing a composition according to claim 51, and

binding the composition to an analyte.

102. The method of claim 101, wherein the analyte is bound to a surface.

103. The method of claim 101, wherein the analyte is in solution.

106. The method of claim 101, wherein the analyte is a protein, an antibody, a drug, or combinations thereof.

109. The method of claim 101, further comprising imaging the bound nanoparticle with real time imaging.

110. The method of claim 101, further comprising detecting the bound nanoparticle under conditions of single molecule detection.

113. The method of claim 101, wherein the binding is carried out in vivo or in vitro.

115. The method of claim 101, wherein the binding is a specific binding.

52-54. -54. (canceled)

56-57. -57. (canceled)

59-60. -60. (canceled)

62. (canceled)

64. (canceled)

66-68. -68. (canceled)

72-76. -76. (canceled)

78-80. -80. (canceled)

81. A method comprising:

providing at least one noble metal nanoparticle,

functionalizing the surface of the noble metal nanoparticle with a first monolayer component and a second monolayer component different from the first.

82. The method of claim 81, wherein the nanoparticle is characterized by a particle size of about 1 nm to about 20 nm.

84. The method of claim 81, wherein the molar ratio of the amount of the first monolayer component to the amount of the second monolayer component is adapted to provide a stability against aggregation of nanoparticles when a collection of the nanoparticles is dispersed in water.

88. The method of claim 81, wherein the first and second monolayer components are mercapto compounds.

92. The method of claim 81, wherein the providing step comprises forming the nanoparticle so that the nanoparticle comprises a third monolayer surface component, and the functionalizing step comprises replacing at least some of the third monolayer surface component.

96. The method of claim 81, wherein the composition comprises the nanoparticles having an average particle size of about 1 nm to about 100 nm.

99. The method of claim 81, wherein the functionalized nanoparticle is dispersible in water.

100. The method of claim 81, wherein the functionalized nanoparticle is not a fluorescent nanoparticle.

83. (canceled)

85-87. -87. (canceled)

89-91. -91. (canceled)

93-95. -95. (canceled)

97-98. -98. (canceled)

104-105. -105. (canceled)

107-108. -108. (canceled)

111-112. -112. (canceled)

114. (canceled)

116-120. -120. (canceled)

121. A method of detecting an analyte using a sensor comprising a sensor molecule coupled to a nanoparticle, the method comprising:

exposing the sensor to the analyte, whereby the sensor molecule selectively binds to the analyte; and

detecting an optical property of the nanoparticle in real-time with single-molecule resolution.

122. The method of claim 121, wherein detecting an optical property of the nanoparticle comprises measuring the localized surface plasmon resonance spectrum of the nanoparticle.

123. The method of claim 121, wherein the sensor molecule comprises a protein or protein fragment and the analyte comprises a protein on a biological cell.

124. The method of claim 123, wherein at least one of the binding kinetics and binding affinity of the protein on the biological cell is measured in real-time.

126. The method of claim 122, wherein a sensor molecule is coupled to the nanoparticle through a mixed monolayer disposed on the surface of the nanoparticle, wherein the mixed monolayer comprises a set of first functional molecules and a set of second functional molecules that differ from the first functional molecules.

125. (canceled)

127. A complex comprising a protein or protein fragment coupled to a nanoparticle, wherein the protein or protein fragment is bound to a protein or protein fragment on the surface of a biological cell, thereby coupling the nanoparticle to the biological cell;

and further wherein the nanoparticle exhibits localized surface plasmon resonance.

128. The complex of claim 127, wherein the protein or protein fragment is coupled to the nanoparticle through a mixed monolayer disposed on the surface of the nanoparticle and further wherein the mixed monolayer comprises a set of first functional molecules and a set of second functional molecules that differ from the first functional molecules.

129. The complex of claim 128, wherein the first functional molecules comprise a functional group capable of forming a covalent attachment to the sensor molecule.

130. The complex of claim 129, wherein the ratio of the first functional molecules to the second functional molecules in the monolayer is from about 1:

1 to about 1;

9.

131. The complex of claim 128, wherein the first and second functional molecules comprises alkanethiols.

134. The complex of claim 128, wherein the nanoparticle is a noble metal nanoparticle.

132-133. -133. (canceled)

135-136. -136. (canceled)